Carisma Therapeutics, Inc. (CARM)
NASDAQ: CARM · Real-Time Price · USD
0.2898
+0.0208 (7.73%)
At close: Sep 26, 2025, 4:00 PM EDT
0.2895
-0.0003 (-0.10%)
After-hours: Sep 26, 2025, 7:58 PM EDT
Carisma Therapeutics Stock Forecast
Stock Price Forecast
According to 3 professional analysts, the 12-month price target for Carisma Therapeutics stock ranges from a low of $0.70 to a high of $1.00. The average analyst price target of $0.90 forecasts a 210.56% increase in the stock price over the next year.
Price Target: $0.90 (+210.56%)
Analyst Consensus: Hold
* Price targets were last updated on Aug 8, 2025.
Analyst Ratings
The average analyst rating for Carisma Therapeutics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 4 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $1 | Strong Buy | Maintains | $1 | +245.07% | Aug 8, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $12 → $1 | Strong Buy | Maintains | $12 → $1 | +245.07% | Apr 1, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +4,040.79% | Jan 17, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +4,040.79% | Jan 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 16, 2024 |
Financial Forecast
Revenue This Year
10.20M
from 19.63M
Decreased by -48.04%
Revenue Next Year
n/a
from 10.20M
EPS This Year
-0.80
from -1.46
EPS Next Year
-0.53
from -0.80
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 21.0M | n/a | |||
| Avg | 10.2M | n/a | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 7.0% | - | |||
| Avg | -48.0% | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.72 | -0.55 | |||
| Avg | -0.80 | -0.53 | |||
| Low | -0.86 | -0.51 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.